PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 209 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,124,000 | -51.0% | 58,965 | -28.7% | 0.01% | -54.5% |
| Q4 2015 | $6,371,000 | +1836.5% | 82,720 | +934.0% | 0.01% | +1000.0% |
| Q3 2015 | $329,000 | -91.6% | 8,000 | -81.9% | 0.00% | -85.7% |
| Q1 2015 | $3,926,000 | -52.2% | 44,195 | -52.4% | 0.01% | -50.0% |
| Q4 2014 | $8,210,000 | -17.7% | 92,842 | -9.8% | 0.01% | -22.2% |
| Q3 2014 | $9,974,000 | -11.0% | 102,911 | -15.7% | 0.02% | -10.0% |
| Q2 2014 | $11,213,000 | +39.5% | 122,071 | +6.3% | 0.02% | +42.9% |
| Q1 2014 | $8,036,000 | +59.2% | 114,827 | +55.3% | 0.01% | +55.6% |
| Q4 2013 | $5,048,000 | +74.8% | 73,959 | +23.2% | 0.01% | +80.0% |
| Q3 2013 | $2,888,000 | +76.9% | 60,046 | +6.6% | 0.01% | +66.7% |
| Q2 2013 | $1,633,000 | – | 56,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |